---
{"dg-publish":true,"permalink":"/jethro-s-working-notes/nucleos-t-ide-reverse-transcriptase-inhibitors-nr/","dgPassFrontmatter":true}
---


# Nucleos(t)ide reverse transcriptase inhibitors (NRTIs)

Created: November 15, 2022 10:02 AM
Tags: GIS, Medicine, Pharmacology
Updated: November 15, 2022 10:08 AM

### Nucleos(t)ide reverse transcriptase inhibitors

Nucleos(t)ide reverse transcriptase inhibitor is a drug that can be used for the pharmacological management of chronic hepatitis B.

- ******************************Examples of NRTIs******************************
    - Entecavir
    - Tenofovir
    - Adefovir
    - Lamivudine
    - Telbivudine
- ************************MOA of NRTIs************************
    
    NRTIs serve as nucleotide analogs, which serves as a competitive inhibitor for HBV reverse transcriptase.
    
    It binds to the growing viral DNA chain, causing premature chain termination, and prevents DNA elongation.
    
    ![[Untitled\|Untitled]]ide%20reverse%20transcriptase%20inhibitors%20(NR%20e832f2307093404b9cb8e005ea1deb0e/Untitled.png)
    
- ******************************************Clinical use of NRTIs******************************************
    
    It is used for the pharmacological management for chronic hepatitis B.
    
    Daily dose for 1 year and longer.
    
- ************************************************Adverse effects of NRTIs************************************************
    
    Headaches, dizziness, nausea.
    
- Pros and cons of NRTIs
    
    ![[Untitled\|Untitled]]ide%20reverse%20transcriptase%20inhibitors%20(NR%20e832f2307093404b9cb8e005ea1deb0e/Untitled%201.png)